Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Streptococcus pneumoniae: new tools for an old pathogen.

S K Hollingshead1, D E Briles

  • 1Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA. hollings@uab.edu

Current Opinion in Microbiology
|February 15, 2001
PubMed
Summary

Pneumococcus, a key pathogen, remains a vital target for new vaccines and antibiotics. Genomics and DNA chip technology are advancing our understanding of its virulence factors and gene expression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pneumococcal Vaccines.

Microbiology spectrum·2019
Same author

Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques.

Mucosal immunology·2015
Same author

Asthma and antibodies to pneumococcal virulence proteins.

Infection·2013
Same author

Evolution of the capsular gene locus of Streptococcus pneumoniae serogroup 6.

Microbiology (Reading, England)·2010
Same author

Prospects for use of interleukin-12 as a mucosal adjuvant for vaccination of humans to protect against respiratory pneumococcal infection.

Vaccine·2008
Same author

Fusion proteins containing family 1 and family 2 PspA fragments elicit protection against Streptococcus pneumoniae that correlates with antibody-mediated enhancement of complement deposition.

Infection and immunity·2007

Area of Science:

  • Microbiology
  • Genomics
  • Pathogenesis

Background:

  • The pneumococcus is a historically significant pathogen, crucial for discoveries like Gram staining and nucleic acid identification.
  • Despite extensive research, combating pneumococcal infections with effective vaccines and antibiotics remains a critical challenge.

Purpose of the Study:

  • To highlight the ongoing importance of the pneumococcus as a pathogen.
  • To emphasize the role of emerging genomic technologies in understanding and combating pneumococcal infections.

Main Methods:

  • Leveraging genomics to identify novel virulence factors.
  • Developing DNA chip technology for gene expression analysis.

Main Results:

  • Genomic approaches are uncovering new virulence factors.

Related Experiment Videos

  • DNA chip technology facilitates analysis of gene expression in specific tissues and regulatory circuits.

    • Conclusions:

    • Continued research into pneumococcal pathogenesis is essential.
    • Genomic insights and advanced technologies like DNA chips are vital for developing new strategies against this pathogen.